Complete Filing Data
Blue Owl Technology Finance Corp. reported Stockholders Equity of $8.04 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Blue Owl Technology Finance Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other General And Administrative Expense | $10.6M | $6.0M | $4.4M | $4.3M | $4.5M |
| Net Income Loss | $720.4M | $319.2M | $369.1M | $19.0M | $424.8M |
| Interest Expense | $321.5M | $192.7M | $195.5M | $136.5M | $93.8M |
| Income Taxes Paid Including Excise Taxes | $11.6M | $10.2M | $7.9M | $3.9M | $324.0K |
| Tax Basis Of Investments Cost For Income Tax Purposes | $14.00B | $6.42B | $6.20B | $6.50B | $5.90B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other General And Administrative Expense | $3.3M | $3.1M | $1.5M | $1.3M | $1.5M | $1.2M | $174.0K | $2.0M | $966.0K | $1.0M | $1.1M | $1.1M |
| Net Income Loss | $234.9M | $201.5M | $78.1M | $119.5M | $8.1M | $90.9M | $56.8M | $113.8M | $96.9M | $153.4M | -$143.7M | -$35.3M |
| Interest Expense | $85.4M | $87.3M | $51.7M | $48.3M | $48.5M | $49.3M | $49.7M | $48.6M | $48.2M | $34.9M | $28.7M | $27.1M |
| Income Taxes Paid Including Excise Taxes | $11.6M | $10.2M | $7.9M | $3.9M | ||||||||
| Tax Basis Of Investments Cost For Income Tax Purposes | $12.60B | $12.50B | $12.00B | $6.43B | $6.23B | $6.10B | $6.30B | $6.50B | $6.60B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $8.04B | $3.63B | $3.53B | $3.39B | $3.53B | $1.50B | $777.2M | $286.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $282.9M | $257.0M | $469.0M | $203.3M | $107.0M | $82.2M | ||
| Unrealized Gain Loss On Investments | $175.2M | $51.4M | -$3.5M | -$295.0M | $188.1M | |||
| Stockholders Equity Period Increase Decrease | $4.42B | $95.2M | $142.6M | -$144.8M | $2.04B | |||
| Distribution Payable | $185.7M | $71.0M | $76.9M | $59.1M | ||||
| Tax Basis Of Investments Gross Unrealized Depreciation | $101.7M | $203.8M | $160.4M | $196.8M | $33.1M | |||
| Tax Basis Of Investments Gross Unrealized Appreciation | $437.2M | $188.0M | $135.0M | $139.1M | $276.4M | |||
| Repayments Of Debt | $2.57B | $382.3M | $1.12B | $903.2M | $2.77B | |||
| Debt And Equity Securities Unrealized Gain Loss | $146.2M | $51.6M | -$6.7M | -$295.5M | $188.9M | |||
| Debt And Equity Securities Realized Gain Loss | $54.6M | -$104.2M | $8.2M | $41.2M | $88.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $25.9M | -$212.0M | $265.7M | $96.3M | $24.8M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $52.3M | $41.9M | $37.1M | $22.5M | $23.3M | |||
| Tax Basis Of Investments Unrealized Appreciation Depreciation Net | -$15.8M | -$25.4M | $57.7M | $243.3M | ||||
| Retained Earnings Accumulated Deficit | $463.2M | $270.8M | $247.2M | $169.2M | ||||
| Restricted Investments Percent Of Net Assets | $0.28 | $0.37 | $0.35 | $0.35 | ||||
| Restricted Investments At Fair Value | $2.20B | $1.35B | $1.20B | $1.2M | ||||
| Prepaid Expense And Other Assets | $56.8M | $10.4M | $1.1M | $902.0K | ||||
| Non Qualifying Assets Percent Of Net Assets | $0.16 | $0.14 | $0.17 | $0.23 | ||||
| Management Fee Payable | $48.6M | $14.7M | $14.3M | $14.2M | ||||
| Long Term Debt | $6.29B | $2.91B | $2.95B | $3.16B | ||||
| Liabilities And Stockholders Equity | $14.72B | $6.72B | $6.65B | $6.66B | ||||
| Liabilities | $6.67B | $3.10B | $3.12B | $3.28B | ||||
| Investment Owned Percent Of Net Assets | $1.78 | $1.76 | $1.74 | $1.89 | ||||
| Interest Receivable | $83.0M | $45.8M | $44.2M | $41.5M | ||||
| Incentive Fee Payable | $68.1M | $11.1M | $17.9M | $15.0M | ||||
| Dividends Receivable | $6.3M | $1.9M | $5.8M | $6.2M | ||||
| Deferred Finance Costs Net | $84.1M | $37.5M | $35.1M | $32.9M | ||||
| Common Stock Value | $4.6M | $2.1M | $2.1M | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $8.06B | $7.99B | $7.95B | $3.58B | $3.51B | $3.57B | $3.48B | $3.49B | $3.43B | $3.39B | $3.28B | $3.46B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $397.1M | $170.5M | $1.00B | $186.5M | $331.2M | $499.8M | $260.9M | $79.3M | $218.3M | $41.5M | $115.8M | $144.4M |
| Unrealized Gain Loss On Investments | $103.4M | $78.1M | -$20.5M | $109.7M | -$93.1M | $22.0M | -$63.7M | $26.6M | $30.8M | $93.1M | -$248.0M | -$104.9M |
| Stockholders Equity Period Increase Decrease | $69.8M | $38.7M | $4.32B | $65.2M | -$54.7M | $35.0M | -$336.0K | $55.9M | $42.0M | $108.5M | -$178.4M | -$74.9M |
| Distribution Payable | $186.6M | $162.8M | $0.00 | $76.5M | $83.1M | $76.4M | $77.0M | $76.2M | $70.2M | |||
| Tax Basis Of Investments Gross Unrealized Depreciation | $78.5M | $67.9M | $135.9M | $190.0M | $231.8M | $163.8M | $176.3M | $151.2M | $180.8M | |||
| Tax Basis Of Investments Gross Unrealized Appreciation | $370.3M | $256.9M | $185.6M | $160.7M | $156.9M | $164.5M | $121.0M | $167.4M | $151.9M | |||
| Repayments Of Debt | $355.0M | $16.4M | $167.9M | $324.5M | ||||||||
| Debt And Equity Securities Unrealized Gain Loss | -$20.7M | $22.6M | $30.8M | -$104.9M | ||||||||
| Debt And Equity Securities Realized Gain Loss | $1.8M | -$22.8M | -$15.5M | $4.2M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $744.0M | $30.8M | $15.0M | $37.4M | ||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $10.6M | $8.4M | $7.0M | $5.8M | ||||||||
| Tax Basis Of Investments Unrealized Appreciation Depreciation Net | $291.8M | $189.0M | $49.7M | -$29.3M | -$74.9M | $700.0K | -$55.3M | $16.2M | -$28.9M | |||
| Retained Earnings Accumulated Deficit | $363.4M | $315.1M | $276.4M | $229.7M | $186.7M | $261.7M | $213.3M | $233.5M | $195.8M | |||
| Restricted Investments Percent Of Net Assets | $0.26 | $0.24 | $0.23 | $0.36 | $0.36 | $0.35 | $0.35 | $0.36 | $0.35 | |||
| Restricted Investments At Fair Value | $2.10B | $1.90B | $1.80B | $1.27B | $1.25B | $1.24B | $1.20B | $1.20B | $1.21B | |||
| Prepaid Expense And Other Assets | $36.0M | $55.4M | $47.7M | $38.0M | $4.4M | $28.8M | $1.1M | $687.0K | $1.5M | |||
| Non Qualifying Assets Percent Of Net Assets | $0.15 | $0.15 | $0.14 | $0.16 | $0.13 | $0.15 | $0.22 | $0.22 | $0.23 | |||
| Management Fee Payable | $48.0M | $32.5M | $27.7M | $14.1M | $14.0M | $14.0M | $14.6M | $14.8M | $14.6M | |||
| Long Term Debt | $4.97B | $4.75B | $5.13B | $2.96B | $2.88B | $2.95B | $2.92B | $2.93B | $3.21B | |||
| Liabilities And Stockholders Equity | $13.40B | $13.04B | $13.22B | $6.69B | $6.55B | $6.67B | $6.56B | $6.56B | $6.79B | |||
| Liabilities | $5.35B | $5.06B | $5.27B | $3.11B | $3.04B | $3.10B | $3.08B | $3.07B | $3.36B | |||
| Investment Owned Percent Of Net Assets | $1.60 | $1.59 | $1.52 | $1.79 | $1.76 | $1.71 | $1.79 | $1.85 | $1.90 | |||
| Interest Receivable | $71.7M | $82.4M | $86.2M | $58.4M | $50.7M | $55.2M | $47.1M | $45.0M | $44.5M | |||
| Incentive Fee Payable | $55.9M | $28.1M | $21.4M | $10.3M | $10.6M | $16.9M | $16.9M | $20.8M | $17.2M | |||
| Dividends Receivable | $11.9M | $5.9M | $13.2M | $5.3M | $6.3M | $8.1M | $7.2M | $998.0K | $6.1M | |||
| Deferred Finance Costs Net | $82.6M | $87.2M | $93.7M | $29.3M | $31.2M | $33.1M | $35.7M | $30.6M | $32.3M | |||
| Common Stock Value | $4.7M | $4.7M | $4.7M | $2.1M | $2.1M | $2.1M | $2.1M | $2.0M | $2.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $4.00B | $347.8M | $901.6M | $1.44B | $3.80B |
| Proceeds From Disposition Of Investment Operating Activity | $1.92B | $1.82B | $1.33B | $666.5M | $1.38B |
| Payments Of Dividends Common Stock | $393.7M | $230.0M | $208.7M | $136.3M | $83.3M |
| Payments Of Debt Issuance Costs | $26.6M | $11.7M | $11.5M | $11.2M | $6.3M |
| Payments For Purchase Of Investment Operating Activity | $3.76B | $1.97B | $849.5M | $1.07B | $4.11B |
| Net Cash Provided By Used In Operating Activities | -$916.0M | $64.2M | $708.4M | -$295.3M | -$2.62B |
| Net Cash Provided By Used In Financing Activities | $941.9M | -$276.2M | -$442.6M | $391.6M | $2.64B |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.0M | $9.3M | $212.0K | -$947.0K | $1.4M |
| Increase Decrease In Payable For Investment Purchased | -$49.8M | $28.6M | $24.2M | -$11.4M | $11.4M |
| Increase Decrease In Management Fee Payable | $22.1M | $435.0K | $9.0K | $890.0K | $4.0M |
| Increase Decrease In Incentive Fee Payable | $46.3M | -$6.8M | $2.9M | -$22.7M | $31.0M |
| Increase Decrease In Due To Affiliates | -$1.8M | $784.0K | -$1.6M | $231.0K | $256.0K |
| Increase Decrease In Dividends Receivable | $4.3M | -$3.9M | -$401.0K | $5.3M | $555.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$109.8M | -$9.1M | $13.6M | $7.8M | $11.7M |
| Increase Decrease In Accrued Interest Receivable Net | -$37.3M | $6.2M | -$462.0K | -$2.0M | $20.4M |
| Increase Decrease In Paid In Kind Interest Receivable | $0.00 | -$4.6M | $3.1M | $527.0K | $5.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Debt | $675.0M | $25.0M | $215.9M | $401.8M |
| Proceeds From Disposition Of Investment Operating Activity | $387.6M | $340.5M | $19.4M | $249.9M |
| Payments Of Dividends Common Stock | $105.6M | $56.4M | $43.8M | $23.6M |
| Payments Of Debt Issuance Costs | $12.6M | $377.0K | $1.4M | $961.0K |
| Payments For Purchase Of Investment Operating Activity | $454.1M | $253.1M | $60.2M | $290.2M |
| Net Cash Provided By Used In Operating Activities | $542.2M | $79.0M | $12.2M | -$15.4M |
| Net Cash Provided By Used In Financing Activities | $201.8M | -$48.2M | $2.8M | $52.8M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$11.0M | $27.7M | $578.0K | -$392.0K |
| Increase Decrease In Payable For Investment Purchased | -$42.1M | -$24.2M | $0.00 | -$11.4M |
| Increase Decrease In Management Fee Payable | $1.2M | -$261.0K | $369.0K | $633.0K |
| Increase Decrease In Incentive Fee Payable | -$417.0K | -$1.1M | $2.2M | -$15.6M |
| Increase Decrease In Due To Affiliates | $384.0K | $976.0K | -$1.4M | -$1.2M |
| Increase Decrease In Dividends Receivable | $11.2M | $2.3M | -$130.0K | $3.9M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$105.3M | -$547.0K | $14.7M | $10.3M |
| Increase Decrease In Accrued Interest Receivable Net | -$34.1M | $11.1M | -$3.6M | -$7.1M |
| Increase Decrease In Paid In Kind Interest Receivable | $4.1M | $6.6M | $2.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $17.33 | $17.09 | $17.03 | $16.70 | $17.65 | $14.88 | $14.70 | $14.53 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 409.4M | 209.8M | 205.0M | 201.4M | 139.2M | 85.4M | 36.7M | 9.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 409.4M | 209.8M | 205.0M | 201.4M | 139.2M | 85.4M | 36.7M | 9.3M | |
| Common Stock Shares Outstanding | 464.0M | 212.2M | 207.3M | 202.9M | 200.1M | 100.59B | 52.9M | 19.74B | |
| Earnings Per Share Diluted | $1.52 | $1.80 | $0.09 | $3.05 | |||||
| Earnings Per Share Basic | $1.52 | $1.80 | $0.09 | $3.05 | |||||
| Common Stock Shares Issued | 464.0M | 212.2M | 207.3M | 202.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Asset Value Per Share | $17.27 | $17.17 | $17.09 | $16.95 | $16.74 | $17.10 | $16.91 | $17.01 | $16.83 | $16.77 | $16.29 | $17.24 |
| Weighted Average Number Of Shares Outstanding Basic | 466.7M | 465.1M | 235.4M | 210.3M | 209.1M | 208.1M | 205.5M | 204.4M | 203.5M | 201.6M | 200.9M | 200.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 466.7M | 465.1M | 235.4M | 210.3M | 209.1M | 208.1M | 205.5M | 204.4M | 203.5M | 201.6M | 200.9M | 200.4M |
| Common Stock Shares Outstanding | 466.5M | 465.1M | 465.1M | 211.0M | 209.7M | 208.5M | 206.0M | 204.9M | 203.8M | 202.0M | 201.3M | 200.6M |
| Earnings Per Share Diluted | $0.50 | $0.43 | $0.33 | $0.57 | $0.04 | $0.44 | $0.28 | $0.56 | $0.48 | $0.76 | $-0.71 | $-0.18 |
| Earnings Per Share Basic | $0.50 | $0.43 | $0.33 | $0.57 | $0.04 | $0.44 | $0.28 | $0.56 | $0.48 | $0.76 | $-0.71 | $-0.18 |
| Common Stock Shares Issued | 466.5M | 465.1M | 465.1M | 211.0M | 209.7M | 208.5M | 206.0M | 204.9M | 203.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $175.2M | $51.4M | -$3.5M | -$295.0M | $188.1M |
| Realized Investment Gains Losses | $33.1M | -$106.3M | $6.5M | $40.8M | $88.9M |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | $208.3M | -$54.9M | $3.0M | -$254.2M | $277.0M |
| Professional Fees | $12.1M | $6.5M | $8.2M | $7.4M | $8.0M |
| Noninterest Expense Directors Fees | $1.1M | $1.0M | $1.0M | $1.1M | $1.0M |
| Net Investment Income | $519.6M | $385.6M | $375.3M | $281.1M | $152.8M |
| Management Fee Expense | $144.9M | $56.7M | $58.4M | $55.8M | $46.8M |
| Investment Income Operating Tax Expense Benefit | $7.5M | $11.5M | $9.1M | $7.9M | $4.9M |
| Investment Income Operating After Expense And Tax | $512.1M | $374.1M | $366.2M | $273.2M | $147.8M |
| Investment Income Investment Expense | $625.9M | $298.4M | $308.5M | $213.7M | $201.4M |
| Investment Company Dividend Distribution | $607.7M | $307.0M | $300.3M | $210.8M | $123.0M |
| Gross Investment Income Operating | $1.15B | $684.0M | $683.8M | $494.8M | $354.1M |
| Foreign Currency Transaction Gain Loss Unrealized | $29.7M | -$263.0K | $3.1M | $488.0K | -$852.0K |
| Foreign Currency Transaction Gain Loss Realized | -$21.5M | -$2.0M | -$1.7M | -$404.0K | $399.0K |
| Amortization Of Financing Costs | $27.1M | $9.3M | $9.3M | $10.3M | $9.3M |
| Stock Issued During Period Value Dividend Reinvestment Plan | $99.2M | $83.0M | $73.8M | $47.0M | $29.1M |
| Investment Company Capital Transactions Increase Decrease | $4.30B | $83.0M | $73.8M | $47.0M | $1.73B |
| Interest Paid Net | $304.7M | $189.5M | $173.4M | $120.1M | $75.5M |
| Foreign Currency Transaction Gain Loss Realized Noncash | $8.0M | -$14.9M | -$22.0K | -$1.6M | $7.0K |
| Distributions Declared | $607.7M | $307.0M | $300.3M | $210.8M | $123.0M |
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$106.3M | $6.5M | $40.8M | $88.9M | |
| Incentive Fee Expense Net | $35.5M | $41.0M | $8.7M | $47.2M | |
| Investment Owned At Fair Value | $14.29B | $6.41B | $6.13B | $6.41B | |
| Investment Owned At Cost | $14.13B | $6.43B | $6.21B | $6.50B |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | $103.4M | $78.1M | -$20.5M | $109.7M | -$93.1M | $22.0M | -$63.7M | $26.6M | $30.8M | $93.1M | -$248.0M | -$104.9M |
| Realized Investment Gains Losses | $1.0M | -$36.9M | $1.3M | -$82.4M | -$578.0K | -$23.7M | $23.5M | $50.0K | -$15.5M | $443.0K | $36.8M | $4.3M |
| Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax | $104.4M | $41.1M | -$19.2M | $27.3M | -$93.7M | -$1.8M | -$40.3M | $26.6M | $15.3M | $93.6M | -$211.2M | -$100.6M |
| Professional Fees | $2.9M | $2.8M | $3.4M | $1.7M | $1.8M | $1.5M | $2.4M | $2.2M | $2.0M | $1.8M | $2.0M | $1.5M |
| Noninterest Expense Directors Fees | $259.0K | $314.0K | $259.0K | $259.0K | $258.0K | $258.0K | $320.0K | $227.0K | $226.0K | $276.0K | $266.0K | $282.0K |
| Net Investment Income | $133.0M | $160.5M | $100.7M | $95.1M | $104.2M | $95.9M | $99.7M | $90.5M | $84.7M | $61.9M | $70.9M | $67.4M |
| Management Fee Expense | $48.0M | $32.5M | $15.9M | $14.1M | $14.0M | $14.0M | $14.6M | $14.8M | $14.6M | $13.6M | $13.9M | $14.0M |
| Investment Income Operating Tax Expense Benefit | $2.4M | $146.0K | $3.4M | $2.8M | $2.5M | $3.3M | $2.6M | $3.3M | $3.1M | $2.1M | $3.3M | $2.1M |
| Investment Income Operating After Expense And Tax | $130.6M | $160.4M | $97.3M | $92.3M | $101.8M | $92.6M | $97.1M | $87.2M | $81.6M | $59.8M | $67.5M | $65.3M |
| Investment Income Investment Expense | $189.6M | $159.0M | $82.1M | $75.8M | $69.9M | $76.3M | $73.4M | $80.7M | $76.8M | $68.6M | $36.6M | $40.1M |
| Investment Company Dividend Distribution | $186.6M | $162.8M | $72.5M | $76.5M | $83.1M | $76.4M | $77.0M | $76.2M | $70.2M | $57.0M | $47.0M | $47.7M |
| Gross Investment Income Operating | $322.6M | $319.5M | $182.8M | $170.9M | $174.2M | $172.3M | $173.0M | $171.2M | $161.5M | $130.5M | $107.5M | $107.5M |
| Foreign Currency Transaction Gain Loss Unrealized | $2.7M | $24.9M | $1.1M | $922.0K | $469.0K | -$598.0K | -$453.0K | $278.0K | $14.0K | -$608.0K | -$292.0K | $19.0K |
| Foreign Currency Transaction Gain Loss Realized | $3.2M | -$24.8M | -$584.0K | $440.0K | -$903.0K | -$928.0K | $10.0K | -$30.0K | -$35.0K | $482.0K | -$85.0K | $42.0K |
| Amortization Of Financing Costs | $5.4M | $7.5M | $3.5M | $2.1M | $2.1M | $2.3M | $3.1M | $2.2M | $2.0M | $1.7M | $1.4M | $1.6M |
| Stock Issued During Period Value Dividend Reinvestment Plan | $30.4M | $0.00 | $22.2M | $20.4M | $20.5M | $19.9M | $18.2M | $15.3M | $12.1M | $12.3M | $8.1M | |
| Investment Company Capital Transactions Increase Decrease | $21.5M | $0.00 | $4.32B | $22.2M | $20.4M | $20.5M | $19.9M | $18.2M | $15.3M | $12.1M | $12.3M | $8.1M |
| Interest Paid Net | $32.8M | $40.6M | $30.7M | $12.4M | ||||||||
| Foreign Currency Transaction Gain Loss Realized Noncash | -$624.0K | -$1.6M | $0.00 | $1.0K | ||||||||
| Distributions Declared | $72.5M | $76.4M | $70.2M | $47.7M | ||||||||
| Realized Gain Loss Investment Derivative And Foreign Currency Transaction Price Change Operating Before Tax | -$82.4M | -$578.0K | -$23.7M | $23.5M | $50.0K | -$15.5M | $443.0K | $36.8M | $4.3M | |||
| Incentive Fee Expense Net | $10.3M | $4.0M | $10.1M | $6.2M | $12.8M | $10.8M | $17.0M | -$9.4M | -$3.9M | |||
| Investment Owned At Fair Value | $12.88B | $12.73B | $12.07B | $6.40B | $6.16B | $6.08B | $6.25B | $6.43B | $6.52B | |||
| Investment Owned At Cost | $12.74B | $12.68B | $12.11B | $6.42B | $6.30B | $6.14B | $6.34B | $6.45B | $6.57B |
Most recent annual filing with the SEC: February 18, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.